SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001576280-21-000079
Filing Date
2021-08-05
Accepted
2021-08-05 16:09:26
Documents
14
Period of Report
2021-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gh-20210805.htm   iXBRL 8-K 38670
2 EX-99.1 gh-06302021xexhibit991.htm EX-99.1 247763
6 GRAPHIC guardantlogoa01.gif GRAPHIC 17260
  Complete submission text file 0001576280-21-000079.txt   465124

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gh-20210805.xsd EX-101.SCH 2011
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gh-20210805_lab.xml EX-101.LAB 24275
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gh-20210805_pre.xml EX-101.PRE 12741
7 EXTRACTED XBRL INSTANCE DOCUMENT gh-20210805_htm.xml XML 10757
Mailing Address 505 PENOBSCOT DR. REDWOOD CITY CA 94063
Business Address 505 PENOBSCOT DR. REDWOOD CITY CA 94063 855-698-8887
Guardant Health, Inc. (Filer) CIK: 0001576280 (see all company filings)

IRS No.: 454139254 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38683 | Film No.: 211148228
SIC: 8071 Services-Medical Laboratories